Drug circulation in the bloodstream
Once they have reached the bloodstream, some drugs bind tightly to proteins in the blood such as albumin. In this form, the drugs are usually inactive and are quickly removed from the body. If a drug is highly protein-bound in this way, the dose is carefully chosen so that a large enough proportion of each dose remains unbound and therefore active in the body.
Some drugs are far more protein-bound than others. If you take two highly protein-bound drugs for example Drug X and Drug Y, Drug X may bind to most of the available protein in the blood, leaving little protein left to bind to Drug Y. That can mean that an unusually high proportion of each dose of Drug Y is left unbound and active, perhaps the equivalent of taking an overdose of Drug Y.
latest aidsmap news
- HIV prevalence may decline because the most vulnerable are infected and die first
- Lack of perceived need for HIV treatment associated with poor adherence
- TB doesn't always increase HIV viral load
- New 75mg darunavir tablet approved by FDA for use by HIV-positive children
- Thyroid checks recommended for people with HIV
- Knighthood for head of UK HIV charity
- Gay men often not accessing PEP despite risk of HIV exposure
- Inflammatory cytokines may contribute to endothelial dysfunction in people with untreated HIV
- Internalised homophobia leads to sexual risk taking by HIV-positive gay men
- Most gay men willing to consider PrEP for possible HIV exposure
